Quinidine – Class IA Antiarrhythmic Drug

What is Quinidine?

Quinidine is an antiarrhythmic agent belonging to class IA of the Vaughan-Williams classification. It is a naturally occurring alkaloid derived from the bark of the cinchona tree (Cinchona species) and is a stereoisomer of the antimalarial drug quinine. In modern medicine, quinidine is used primarily in cardiology for the management of certain cardiac arrhythmias (irregular heart rhythms).

Indications

Quinidine is indicated for:

• Atrial fibrillation and atrial flutter – to restore normal sinus rhythm (cardioversion)
• Ventricular tachycardia – dangerous rapid heart rhythms originating in the ventricles
• Supraventricular tachycardias – rapid rhythms originating above the ventricles
• Brugada syndrome – a rare, genetically determined heart condition associated with an increased risk of sudden cardiac death

Mechanism of Action

Quinidine exerts its antiarrhythmic effect primarily by blocking voltage-gated sodium channels in cardiac muscle cells. This slows the rate of electrical depolarization, reducing the speed at which electrical impulses travel through the heart. Additionally, quinidine prolongs the refractory period – the time after excitation during which a cardiac cell cannot be re-stimulated. This interrupts reentry circuits, which are a common cause of sustained arrhythmias. Quinidine also blocks potassium channels, leading to prolongation of the QT interval on the ECG, and exhibits anticholinergic and alpha-adrenoceptor-blocking properties.

Dosage and Administration

Quinidine is typically administered orally in tablet form. The dosage depends on the indication, body weight, and renal function of the patient, and must always be determined individually by the treating physician. Common dosage ranges are 200–400 mg taken several times daily. Treatment with quinidine requires regular ECG monitoring to detect potentially dangerous QT prolongation at an early stage.

Side Effects

Quinidine can cause a range of side effects, including:

• Cinchonism: a characteristic toxicity syndrome involving tinnitus (ringing in the ears), dizziness, headache, visual disturbances, and nausea
• QT prolongation and risk of life-threatening arrhythmias such as torsades de pointes
• Gastrointestinal complaints: nausea, vomiting, diarrhea
• Hypotension (low blood pressure)
• Allergic reactions, including thrombocytopenia (reduced platelet count)
• Hepatotoxicity (in rare cases)

Drug Interactions

Quinidine has numerous clinically significant drug interactions:

• Elevation of digoxin plasma levels – may lead to digitalis toxicity
• Potentiation of oral anticoagulants (e.g., warfarin) – increased bleeding risk
• Combination with other QT-prolonging medications is contraindicated
• Inhibition of the liver enzyme CYP2D6 – affects the metabolism of numerous other drugs

Contraindications

Quinidine must not be used in patients with:

• Second- or third-degree AV block without a pacemaker
• Known QT prolongation or history of torsades de pointes
• Severe heart failure
• Hypersensitivity to quinidine or other cinchona alkaloids

References

1. Brunton, L.L., Hilal-Dandan, R. & Knollmann, B.C. (Eds.) – Goodman & Gilman's The Pharmacological Basis of Therapeutics. 13th Edition, McGraw-Hill Education, 2018.
2. European Heart Rhythm Association (EHRA) – Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. European Heart Journal, 2022.
3. Roden, D.M. – Antiarrhythmic Drugs. In: Harrison's Principles of Internal Medicine, 21st Edition, McGraw-Hill, 2022.